Cargando…
The chemokine CXCL13 in cerebrospinal fluid in children with Lyme neuroborreliosis
Anti-Borrelia antibodies in the cerebrospinal fluid (CSF) are required for definite diagnosis of Lyme neuroborreliosis (LNB). However, children often present with early LNB, and antibody production in the CSF may not be demonstrated. Recent studies have suggested the chemokine CXCL13 to be an early...
Autores principales: | Henningsson, Anna J., Lager, Malin, Brännström, Rebecka, Tjernberg, Ivar, Skogman, Barbro H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154094/ https://www.ncbi.nlm.nih.gov/pubmed/30083887 http://dx.doi.org/10.1007/s10096-018-3334-3 |
Ejemplares similares
-
The recomBead Borrelia antibody index, CXCL13 and total IgM index for laboratory diagnosis of Lyme neuroborreliosis in children
por: Skogman, B. H., et al.
Publicado: (2017) -
CXCL13 in laboratory diagnosis of Lyme neuroborreliosis—the performance of the recomBead and ReaScan CXCL13 assays in human cerebrospinal fluid samples
por: Haglund, Sofie, et al.
Publicado: (2021) -
Brain damage markers neuron-specific enolase (NSE) and S100B in serum in children with Lyme neuroborreliosis—detection and evaluation as prognostic biomarkers for clinical outcome
por: Arnason, Sigurdur, et al.
Publicado: (2022) -
Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection
por: Bremell, Daniel, et al.
Publicado: (2013) -
The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis
por: Rupprecht, Tobias A, et al.
Publicado: (2009)